The outlook of companies tied to the drug's history presents a challenging investment scenario . While the initial boom generated substantial returns , generic copies have significantly diminished revenue. https://bookmarkfavors.com/story7343818/copyright-s-flagship-product-and-big-pharma-a-uncertain-investment